Your browser doesn't support javascript.
loading
Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial.
Cerbin, Lukasz P; Ambrosy, Andrew P; Greene, Stephen J; Armstrong, Paul W; Butler, Javed; Coles, Adrian; DeVore, Adam D; Ezekowitz, Justin A; Hernandez, Adrian F; Metra, Marco; Starling, Randall C; Tang, Wilson; Teerlink, John R; Voors, Adriaan A; Wu, Angie; O'Connor, Christopher M; Mentz, Robert J.
Afiliación
  • Cerbin LP; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina. Electronic address: lukasz.p.cerbin@duke.edu.
  • Ambrosy AP; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
  • Greene SJ; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
  • Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Butler J; Division of Cardiology, Stony Brook University, Stony Brook, New York.
  • Coles A; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
  • DeVore AD; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
  • Ezekowitz JA; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.
  • Hernandez AF; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
  • Metra M; Cardiology, University of Brescia, Brescia, Italy.
  • Starling RC; Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Tang W; Heart and Vascular Institute, Cleveland Clinic Foundation, Cleveland, Ohio.
  • Teerlink JR; Section of Cardiology, San Francisco Veteran Affairs Medical Center, and School of Medicine, University of California-San Francisco, San Francisco, California.
  • Voors AA; University of Groningen, Groningen, the Netherlands.
  • Wu A; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
  • O'Connor CM; Inova Heart and Vascular Institute, Falls Church, Virginia.
  • Mentz RJ; Department of Internal Medicine, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, North Carolina, Durham, North Carolina.
JACC Heart Fail ; 6(4): 298-307, 2018 04.
Article en En | MEDLINE | ID: mdl-29525328
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vasodilatadores / Mortalidad / Nitroglicerina / Atención Posterior / Inhibidores del Simportador de Cloruro Sódico y Cloruro Potásico / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JACC Heart Fail Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vasodilatadores / Mortalidad / Nitroglicerina / Atención Posterior / Inhibidores del Simportador de Cloruro Sódico y Cloruro Potásico / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JACC Heart Fail Año: 2018 Tipo del documento: Article